Conference call and webcast with Masimo to begin at 2:00 pm PT (5:00 pm ET)
IRVINE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Masimo Corporation
(Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion
and Low Perfusion pulse oximetry, today announced it will release fourth
quarter and fiscal year 2007 financial results for the period ended
December 29, 2007, after the market closes on Tuesday, February 26, 2008.
A conference call to review the results will begin at 2:00 p.m. PT
(5:00 p.m. ET) and will be hosted by Joe E. Kiani, Chairman and Chief
Executive Officer, and Mark P. de Raad, Executive Vice President & Chief
Financial Officer.
A live web cast of the conference call will be available online from the
investor relations page of the Company's corporate web site at
http://www.masimo.com. The dial-in numbers are (800) 295-4740 for domestic
callers and (617) 614-3925 for international callers. The reservation number
for both dial-in numbers is 39491099. After the live web cast, the call will
remain available on Masimo's web site through March 26, 2008. In addition, a
telephonic replay of the call will be available until March 10, 2008. The
replay dial-in numbers are (888) 286-8010 for domestic callers and
(617) 801-6888 for international callers. Please use reservation code
89834871.
About Masimo
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that
significantly improve patient care-helping solve "unsolvable" problems. In
1995, the company debuted Measure-Through Motion and Low Perfusion pulse
oximetry, known as Masimo SET, and with it virtually eliminated false alarms
and increased pulse oximetry's ability to detect life-threatening events. More
than 100 independent and objective studies demonstrate Masimo SET provides the
most trustworthy SpO2 and pulse rate measurements even under the most
difficult clinical conditions, including patient motion and low peripheral
perfusion. In 2005, Masimo introduced Masimo Rainbow SET, a breakthrough
noninvasive blood constituent monitoring platform that can measure many blood
constituents that previously required invasive procedures. Rainbow SET
continuously and noninvasively measures carboxyhemoglobin (SpCO(TM)) and
methemoglobin (SpMet(TM)), pleth variability index (PVI(TM)), in addition to
oxyhemoglobin (SpO2), perfusion index (PI) and pulse rate, allowing early
detection and treatment of potentially life-threatening conditions. Founded in
1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost
of Care by Taking Noninvasive Monitoring to New Sites and Applications."
Additional information about Masimo and its products may be found at
http://www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Rainbow, SpCO, SpMet, PVI and Pulse CO-Oximeter are trademarks or registered
trademarks of Masimo Corporation.
SOURCE Masimo Corporation
CONTACT: Investors, Mark P. de Raad, Executive Vice President and Chief
Financial Officer, +1-949-297-7080, mderaad@masimo.com, or Media, Dana Banks,
Manager, Public Relations, +1-949-297-7348, dbanks@masimo.com, both of Masimo
Corporation
Web site: http://www.masimo.com